Order Article Reprints

Kobayashi T, Nitta M, Shimizu K, Saito T, Tsuzuki S, Fukui A, Koriyama S, Kuwano A, Komori T, Masui K, et al. Therapeutic Options for Recurrent Glioblastoma—Efficacy of Talaporfin Sodium Mediated Photodynamic Therapy. Pharmaceutics. 2022; 14(2):353. https://doi.org/10.3390/pharmaceutics14020353

Kobayashi, Tatsuya, Masayuki Nitta, Kazuhide Shimizu, Taiichi Saito, Shunsuke Tsuzuki, Atsushi Fukui, Shunichi Koriyama, Atsushi Kuwano, Takashi Komori, Kenta Masui, and et al. 2022. "Therapeutic Options for Recurrent Glioblastoma—Efficacy of Talaporfin Sodium Mediated Photodynamic Therapy" Pharmaceutics 14, no. 2: 353. https://doi.org/10.3390/pharmaceutics14020353

Kobayashi, T., Nitta, M., Shimizu, K., Saito, T., Tsuzuki, S., Fukui, A., Koriyama, S., Kuwano, A., Komori, T., Masui, K., Maehara, T., Kawamata, T., & Muragaki, Y. (2022). Therapeutic Options for Recurrent Glioblastoma—Efficacy of Talaporfin Sodium Mediated Photodynamic Therapy. Pharmaceutics, 14(2), 353. https://doi.org/10.3390/pharmaceutics14020353